Stock Spotlight: Ramsay Health Care Ltd (ASX:RHC)
This week's Stock Spotlight is ASX-listed Ramsay Health Care Ltd.
About Ramsay Health Care
Ramsay Health Care Limited is a global hospital group owning and operating a comprehensive range of healthcare facilities across Australia, France and the United Kingdom.
The Company offers private hospital services, including, rehabilitation, psychiatric care, day, and complex surgery.
Key Stats
Key Stats
Data as of 03/09/25.
Price Performance
Growth Potential
- RHC has a diversified portfolio with significant scale (difficult to replicate) and leading positions in Australia and UK.
- Largest private hospital operator in Australia, with attractive industry fundamentals: aging and growing population, proliferation of chronic disease, and increasing innovation, treatment, and technologies to drive demand to private hospitals over the long-term.
- Successful execution of Ramsay Australia 2030 could materially lift returns. Additionally, the potential sale of Ramsay Sante could also be a positive for the share price.
- Supportive government policy (tax incentive to get private health insurance).
- Ongoing brownfield program driving earnings and offshore earnings growth (e.g. UK & turnaround in Elysium).
- Potential M&A – the threat of Private Equity taking RHC private and unlocking the underlying value in the property portfolio.
Key Risks
- Competitive risk (new hospitals, new beds), from listed and unlisted hospital operators.
- Brownfield projects fail to deliver the earnings uplift.
- Cost pressures (negotiating price increases with private health insurance companies) plus inflationary pressures lead to erosion of margins.
- Change to government policy on private health insurance.
- Execution risk (able to get the uplift in earnings from brownfield projects).
Subscribe to our newsletter
Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.
Speak to an Advisor
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.
